amiodarone has been researched along with Peripheral Vascular Diseases in 1 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Peripheral Vascular Diseases: Pathological processes involving any one of the BLOOD VESSELS in the vasculature outside the HEART.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Farooq, V | 1 |
Serruys, PW | 1 |
Bourantas, C | 1 |
Vranckx, P | 1 |
Diletti, R | 1 |
Garcia Garcia, HM | 1 |
Holmes, DR | 1 |
Kappetein, AP | 1 |
Mack, M | 1 |
Feldman, T | 1 |
Morice, MC | 1 |
Colombo, A | 1 |
Morel, MA | 1 |
de Vries, T | 1 |
van Es, GA | 1 |
Steyerberg, EW | 1 |
Dawkins, KD | 1 |
Mohr, FW | 1 |
James, S | 1 |
Ståhle, E | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Synergy Between PCI With TAXUS and Cardiac Surgery: SYNTAX Extended Survival[NCT03417050] | 2,636 participants (Actual) | Observational | 2016-12-31 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for amiodarone and Peripheral Vascular Diseases
Article | Year |
---|---|
Incidence and multivariable correlates of long-term mortality in patients treated with surgical or percutaneous revascularization in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial.
Topics: Aged; Amiodarone; Coronary Artery Bypass; Coronary Artery Disease; Female; Gastrointestinal Hemorrha | 2012 |